Evidence map›Paper›PMID 23245605›Full record

ArticleLancet (London, England)2012

Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.

Joshua A Salomon, Theo Vos, Daniel R Hogan, Michael Gagnon, Mohsen Naghavi, Ali Mokdad, Nazma Begum, Razibuzzaman Shah, Muhammad Karyana, Soewarta Kosen and 118 more

Erratum issued 2 registry-linked trialsAbstract read
In one paragraph

Article in Lancet (London, England), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 2 registered trials, which are not on this map. Cited by 647 papers, 17 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
647citing papers in PubMed, 17 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01872364 completednot on this mapstarted 2013, after this paper: background citation

A Material Cost-Minimization Analysis for Hernia Repairs and Minor Procedures During a Surgical Mission in the Dominican Republic

TypeobservationalSponsorWashington University School of MedicineRan2013 to 2013Enrolled110ConditionsHernia, Hydrocele
NCT06415461 phase1active not recruitingnot on this mapstarted 2024, after this paper: background citation

A Phase 1, Open Label Dose-Ranging Study to Assess the Safety, Tolerability, Preliminary Efficacy, and Dose Effect of CFL001 Cord Blood Product in Patients With Symptomatic Sacroiliac Joint Syndrome

TypeinterventionalSponsorUniversity of FloridaRan2024 to 2028Enrolled9ConditionsSacroiliac, Backache, Pain, BackArmsPremierMaxCB®-Platinum (CFL001)
3 · Its place in the literature

Who cites it

647 citing papers in PubMed, 17 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Lurasidone versus typical antipsychotics for schizophrenia.The Cochrane database of systematic reviews · 2025
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. The efficacy of primary sacroiliac joint fusion for low back pain caused by sacroiliac joint pathology: a systematic review and meta-analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2022
    Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Trial
  19. Trial
  20. Trial

587 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

128 authors.

Joshua A SalomonHarvard School of Public Health, MA, USA. jsalomon@hsph.harvard.edu
Theo Vos
Daniel R Hogan
Michael Gagnon
Mohsen Naghavi
Ali Mokdad
Nazma Begum
Razibuzzaman Shah
Muhammad Karyana
Soewarta Kosen
Mario Reyna Farje
Gilberto Moncada
Arup Dutta
Sunil Sazawal
Andrew Dyer
Jason Seiler
Victor Aboyans
Lesley Baker
Amanda Baxter
Emelia J Benjamin
Kavi Bhalla
Aref Bin Abdulhak
Fiona Blyth
Rupert Bourne
Tasanee Braithwaite
Peter Brooks
Traolach S Brugha
Claire Bryan-Hancock
Rachelle Buchbinder
Peter Burney
Bianca Calabria
Honglei Chen
Sumeet S Chugh
Rebecca Cooley
Michael H Criqui
Marita Cross
Kaustubh C Dabhadkar
Nabila Dahodwala
Adrian Davis
Louisa Degenhardt
Cesar Díaz-Torné
E Ray Dorsey
Tim Driscoll
Karen Edmond
Alexis Elbaz
Majid Ezzati
Valery Feigin
Cleusa P Ferri
Abraham D Flaxman
Louise Flood
Marlene Fransen
Kana Fuse
Belinda J Gabbe
Richard F Gillum
Juanita Haagsma
James E Harrison
Rasmus Havmoeller
Roderick J Hay
Abdullah Hel-Baqui
Hans W Hoek
Howard Hoffman
Emily Hogeland
Damian Hoy
Deborah Jarvis
Ganesan Karthikeyan
Lisa Marie Knowlton
Tim Lathlean
Janet L Leasher
Stephen S Lim
Steven E Lipshultz
Alan D Lopez
Rafael Lozano
Ronan Lyons
Reza Malekzadeh
Wagner Marcenes
Lyn March
David J Margolis
Neil McGill
John McGrath
George A Mensah
Ana-Claire Meyer
Catherine Michaud
Andrew Moran
Rintaro Mori
Michele E Murdoch
Luigi Naldi
Charles R Newton
Rosana Norman
Saad B Omer
Richard Osborne
Neil Pearce
Fernando Perez-Ruiz
Norberto Perico
Konrad Pesudovs
David Phillips
Farshad Pourmalek
Martin Prince
Jürgen T Rehm
Guiseppe Remuzzi
Kathryn Richardson
Robin Room
Sukanta Saha
Uchechukwu Sampson
Lidia Sanchez-Riera
Maria Segui-Gomez
Saeid Shahraz
Kenji Shibuya
David Singh
Karen Sliwa
Emma Smith
Isabelle Soerjomataram
Timothy Steiner
Wilma A Stolk
Lars Jacob Stovner
Christopher Sudfeld
Hugh R Taylor
Imad M Tleyjeh
Marieke J van der Werf
Wendy L Watson
David J Weatherall
Robert Weintraub
Marc G Weisskopf
Harvey Whiteford
James D Wilkinson
Anthony D Woolf
Zhi-Jie Zheng
Christopher J L Murray
Jost B Jonas

Funding

Prospective studies on Parkinson's diseaseZIAES101986 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CHEN, HONGLEI · 2009 to 2016
$7.9M
Mechanisms of health disparities in parkinsonismK23AG034236 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAHODWALA, NABILA · 2010 to 2014
$793k
Forecasting the Cardiovascular Disease Epidemic in ChinaK08HL089675 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MORAN, ANDREW EDWARD · 2008 to 2012
$650k
Department of HealthMedical Research Council G0901214NHLBI NIH HHS K08 HL089675NIA NIH HHS K23 AG034236Wellcome Trust 092654Wellcome Trust 095009
6 · The paper itself

Abstract

backgroundMeasurement of the global burden of disease with disability-adjusted life-years (DALYs) requires disability weights that quantify health losses for all non-fatal consequences of disease and injury. There has been extensive debate about a range of conceptual and methodological issues concerning the definition and measurement of these weights. Our primary objective was a comprehensive re-estimation of disability weights for the Global Burden of Disease Study 2010 through a large-scale empirical investigation in which judgments about health losses associated with many causes of disease and injury were elicited from the general public in diverse communities through a new, standardised approach.

methodsWe surveyed respondents in two ways: household surveys of adults aged 18 years or older (face-to-face interviews in Bangladesh, Indonesia, Peru, and Tanzania; telephone interviews in the USA) between Oct 28, 2009, and June 23, 2010; and an open-access web-based survey between July 26, 2010, and May 16, 2011. The surveys used paired comparison questions, in which respondents considered two hypothetical individuals with different, randomly selected health states and indicated which person they regarded as healthier. The web survey added questions about population health equivalence, which compared the overall health benefits of different life-saving or disease-prevention programmes. We analysed paired comparison responses with probit regression analysis on all 220 unique states in the study. We used results from the population health equivalence responses to anchor the results from the paired comparisons on the disability weight scale from 0 (implying no loss of health) to 1 (implying a health loss equivalent to death). Additionally, we compared new disability weights with those used in WHO's most recent update of the Global Burden of Disease Study for 2004.

findings13,902 individuals participated in household surveys and 16,328 in the web survey. Analysis of paired comparison responses indicated a high degree of consistency across surveys: correlations between individual survey results and results from analysis of the pooled dataset were 0·9 or higher in all surveys except in Bangladesh (r=0·75). Most of the 220 disability weights were located on the mild end of the severity scale, with 58 (26%) having weights below 0·05. Five (11%) states had weights below 0·01, such as mild anaemia, mild hearing or vision loss, and secondary infertility. The health states with the highest disability weights were acute schizophrenia (0·76) and severe multiple sclerosis (0·71). We identified a broad pattern of agreement between the old and new weights (r=0·70), particularly in the moderate-to-severe range. However, in the mild range below 0·2, many states had significantly lower weights in our study than previously.

interpretationThis study represents the most extensive empirical effort as yet to measure disability weights. By contrast with the popular hypothesis that disability assessments vary widely across samples with different cultural environments, we have reported strong evidence of highly consistent results.

fundingBill & Melinda Gates Foundation.

Indexed as

Disability EvaluationHealth StatusAdolescentAdultAgedBangladeshEmpirical ResearchFemaleHealth SurveysHumansIndonesiaInternetMaleMiddle AgedPeruQuality-Adjusted Life Years

Identifiers

PMID23245605
PMCPMC10782811

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.